Leadership Overview
Novotech has 10 executives leading key functions including strategy, financial oversight, operational management, medical expertise, and human resources.
Committed to accelerating the development of novel therapeutics, Novotech partners with global biotech firms to deliver full-service clinical research solutions that drive medical innovation across every development phase.
Committed to accelerating the development of novel therapeutics, Novotech partners with global biotech firms to deliver full-service clinical research solutions that drive medical innovation across every development phase.
Leadership Roles at Novotech
John Moller - Chief Executive Officer
John Moller, the Chief Executive Officer at Novotech, directs the overarching corporate strategy and global expansion initiatives. Moller architects the long-term vision for this clinical contract research organization, ensuring alignment between internal capabilities and the evolving needs of biotech partners. By overseeing high-level partnerships, the Chief Executive Officer drives the company mission to accelerate therapeutic development. Moller maintains rigorous standards across all international operations, fostering a culture of excellence and scientific integrity. This leadership role involves constant engagement with the board to secure sustainable growth and market dominance. Through strategic resource allocation, John Moller optimizes the organizational structure to support complex clinical trials. Ultimately, the Chief Executive Officer ensures that the firm remains a premier partner for biotech companies seeking to navigate the intricacies of global drug development while maintaining a focus on operational efficiency and superior clinical outcomes.
Ekaterina Galperina - Chief Financial Officer
Ekaterina Galperina, the Chief Financial Officer at Novotech, manages the fiscal health and capital allocation strategies for the organization. Galperina oversees financial reporting, budgeting, and risk management frameworks that support the company's global clinical research operations. By analyzing market trends, the Chief Financial Officer ensures that financial resources align with the strategic goals of biotech partners. Ekaterina Galperina directs the financial planning processes, providing the necessary data to inform executive decision-making and long-term investment strategies. This role involves maintaining transparency with stakeholders and ensuring compliance with international financial regulations. Through meticulous oversight of the balance sheet, the Chief Financial Officer strengthens the firm's ability to scale operations across diverse geographic markets. Ultimately, Galperina secures the financial stability required to sustain the company's commitment to accelerating the development of advanced therapeutics for clients worldwide.
Vivek Kapoor - Group Chief Financial Officer
Vivek Kapoor, the Group Chief Financial Officer at Novotech, leads the consolidated financial strategy and corporate treasury functions. Kapoor oversees the financial performance of the entire group, ensuring that capital structures support the company's mission to accelerate therapeutic development. By managing complex financial modeling and tax planning, the Group Chief Financial Officer provides the strategic insights necessary for global expansion. Vivek Kapoor directs the integration of financial systems across international subsidiaries, maintaining consistency in reporting and compliance. This role involves collaborating with the executive team to evaluate potential acquisitions and strategic partnerships that enhance the firm's market position. Through rigorous financial oversight, the Group Chief Financial Officer optimizes cash flow and profitability. Ultimately, Kapoor ensures that the organization possesses the fiscal strength to invest in cutting-edge research capabilities and maintain a competitive edge in the global clinical research market.
Michael Stibilj - Chief Operating Officer
Michael Stibilj, the Chief Operating Officer at Novotech, manages the execution of clinical trial services and internal operational workflows. Stibilj directs the delivery of full-service research solutions, ensuring that project timelines and quality standards meet the rigorous demands of biotech clients. By optimizing cross-functional processes, the Chief Operating Officer enhances the efficiency of clinical development programs. Michael Stibilj oversees the integration of technology and human capital to streamline trial management across global regions. This leadership role involves coordinating with department heads to resolve operational bottlenecks and improve service delivery. Through the implementation of standardized protocols, the Chief Operating Officer drives consistent performance across all research phases. Ultimately, Stibilj ensures that the organization maintains its reputation for excellence by delivering high-quality data and reliable results that support the successful advancement of novel therapeutics for the global biotech industry.
Joseph Dumais - President
Joseph Dumais, the President at Novotech, directs the day-to-day business operations and strategic execution of the company's service portfolio. Dumais oversees the alignment of regional business units with the overarching corporate goals, ensuring that the firm delivers consistent value to biotech partners. By managing the operational performance of key service lines, the President drives the efficiency of clinical research delivery. Joseph Dumais coordinates with the executive team to implement growth strategies that expand the company's footprint in the global market. This role involves overseeing the execution of large-scale clinical programs and ensuring that client expectations are met or exceeded. Through the management of operational resources, the President optimizes the firm's ability to handle complex therapeutic development projects. Ultimately, Dumais ensures that the organization maintains its competitive advantage by delivering high-quality, reliable research services that accelerate the development of novel therapeutics for clients worldwide.
Funsho Ojebuoboh - President & Owner
Funsho Ojebuoboh, the President & Owner at Novotech, directs the high-level strategic vision and long-term ownership objectives of the organization. Ojebuoboh oversees the fundamental values and mission-driven initiatives that guide the company's approach to clinical research. By maintaining a focus on sustainable growth and market leadership, the President & Owner ensures that the firm remains a trusted partner for biotech companies. Funsho Ojebuoboh directs the strategic direction of the business, evaluating long-term opportunities that align with the company's commitment to accelerating therapeutic development. This role involves providing the necessary leadership to maintain the firm's independence and unique service culture. Through the oversight of core business principles, the President & Owner fosters an environment of innovation and excellence. Ultimately, Ojebuoboh secures the company's future by ensuring that all strategic decisions support the overarching goal of delivering superior clinical research solutions to the global biotech industry.
Melinda Borrelli - Head of Medical Office Chief & Chief Marketing Officer, Operations
Melinda Borrelli, the Head of Medical Office Chief & Chief Marketing Officer, Operations at Novotech, directs the intersection of medical strategy and market positioning. Borrelli oversees the development of clinical messaging and ensures that the company's service offerings resonate with the specific needs of biotech innovators. By aligning medical expertise with marketing initiatives, the Head of Medical Office Chief & Chief Marketing Officer, Operations drives the firm's brand presence in the global research landscape. Melinda Borrelli manages the communication of clinical capabilities to potential partners, highlighting the organization's ability to accelerate therapeutic development. This role involves leading cross-functional teams to ensure that marketing materials accurately reflect the scientific rigor of the company's services. Through strategic outreach, the Head of Medical Office Chief & Chief Marketing Officer, Operations expands the firm's reach into new therapeutic areas. Ultimately, Borrelli strengthens the company's market impact by bridging the gap between complex medical data and client-focused solutions.
Tim Bray - Chief Human Resources Officer
Tim Bray, the Chief Human Resources Officer at Novotech, directs the talent acquisition, retention, and organizational development strategies. Bray oversees the recruitment of top-tier scientific and clinical professionals who drive the company's research success. By fostering a culture of innovation and professional growth, the Chief Human Resources Officer ensures that the workforce remains equipped to handle the complexities of global clinical trials. Tim Bray manages performance management systems and leadership development programs that align with the firm's long-term objectives. This role involves implementing policies that promote diversity, equity, and inclusion across all international operations. Through the strategic management of human capital, the Chief Human Resources Officer enhances employee engagement and operational productivity. Ultimately, Bray builds the organizational foundation necessary to support the company's mission of accelerating the development of novel therapeutics by attracting and retaining the best talent in the industry.
Judith Ng-Cashin - Chief Medical Officer
Judith Ng-Cashin, the Chief Medical Officer at Novotech, directs the medical strategy and clinical oversight for all research programs. Ng-Cashin oversees the scientific integrity of clinical trials, ensuring that protocols meet the highest regulatory and ethical standards. By providing expert guidance on therapeutic development, the Chief Medical Officer supports biotech partners in navigating complex clinical pathways. Judith Ng-Cashin leads the medical team in designing robust study plans that maximize the probability of success for novel therapeutics. This role involves collaborating with regulatory bodies and internal project teams to ensure patient safety and data quality. Through the application of deep medical expertise, the Chief Medical Officer drives the scientific excellence that defines the company's service offerings. Ultimately, Ng-Cashin ensures that the organization delivers high-quality clinical outcomes that accelerate the path from research to patient care for clients across the globe.
Kristin Brown - Chief Legal Officer
Kristin Brown, the Chief Legal Officer at Novotech, directs the legal strategy, compliance frameworks, and risk mitigation efforts. Brown oversees the negotiation of complex clinical trial agreements and service contracts, ensuring that the company's interests remain protected while fostering collaborative partnerships. By managing intellectual property and regulatory compliance, the Chief Legal Officer provides the legal foundation for the firm's global operations. Kristin Brown directs the legal team in navigating the diverse regulatory landscapes of international markets. This role involves advising the executive team on legal risks associated with new service offerings and market expansion. Through proactive legal management, the Chief Legal Officer ensures that all research activities adhere to global standards and ethical guidelines. Ultimately, Brown safeguards the organization's reputation and operational continuity, allowing the firm to focus on its core mission of accelerating the development of advanced therapeutics for biotech clients.
Explore Leadership Teams in Business Services
About Commonwealth Scientific and Industrial Research Organisation (CSIRO) CSIRO is Australia's national science agency and innovation catalyst. We solve the greatest challenges through innovative science and technology, unlocking a better future for our community, our economy, our planet. CSIRO's collaborative research turns science into solutions to address Australia's greatest challenges, including food security and quality; clean energy and resources; health and wellbeing; resilient and valuable environments; innovative industries; and a secure Australia and region.
Company Leadership DA
TM
KC
A global leader in applied safety science, UL Solutions transforms safety, security and sustainability challenges into opportunities for customers. We deliver testing, inspection and certification services, plus software and advisory offerings that support our customers product innovation and business growth.
Company Leadership
CZ
CS
Founded in 2002, Torch Technologies provides research, development, and engineering services to the Department of Defense. The company is headquartered in Huntsville, Alabama.
Company Leadership DL
CC
Central Metallurgical Research and Development Institute (CMRDI) is a research institute affiliated to the Ministery of Scientific Research. The mission of the institute is to enhance the competitiveness of the Egyptian industry and the welfare of the society through technological development and technology transfer. CMRDI offers services to industry covering research projects, consultancy, technical services, training, testing and certification. Over almost three decades of collaboration with Egyptian industry, these services have been focused on the actual demands of the client and application in the company, giving the institute a profile of needs pull rather than technology push. CMRDI has a longstanding and successful collaboration with many national and overseas R&D institutions, which guarantees a sound scientific basis. CMRDI has also largely benefited from cooperation with international agencies such as JICA (Japan), TNO (Netherlands) and SIDA (Sweden). Thanks to this support, CMRDI was able to play an effective role in transferring many technologies to the Egyptian industries as well as other African and Middle-East countries.
Company Leadership AY
AN
MN
BZ
Frequently Asked Questions Regarding Novotech Top Executives and Leadership Team
